Dopaminergic drugs decrease loss aversion in Parkinson’s disease with but not without depression
Monique H.M. Timmer, Guillaume Sescousse, Rianne A.J. Esselink, Payam Piray, Roshan Cools
This study shows dopaminergic drugs reduce loss aversion in Parkinson’s disease patients with depression but not without it, linking drug effects to depression severity.
bioRxiv · Aug 11, 2016 · PreprintNeuroscience